Tobacco dependence is the leading cause of death in persons with psychiatric and substance use disorders. This has lead to interest in the development of pharmacological and behavioral treatments for tobacco dependence in this subset of smokers. However, there has been little attention paid to the development of tobacco-free environments in psychiatric institutions despite the creation of smoke-free psychiatric hospitals mandated by the Joint Commission for Accreditation of Health Organizations (JCAHO) in 1992. This review article addresses the reasons why tobacco should be excluded from psychiatric and addictions treatment settings, and strategies that can be employed to initiate and maintain tobacco-free psychiatric settings. Finally, questions for further research in this field are delineated. This Tobacco Reconceptualization in Psychiatry is long overdue, given the clear and compelling benefits of tobacco-free environments in psychiatric institutions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918288 | PMC |
| http://dx.doi.org/10.1111/j.1521-0391.2010.00051.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of Insurance Status With Provision of Recommended Services During Comprehensive Postpartum Visits.
JAMA Netw Open
November 2020
Department of Health Promotion and Policy, University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst.
Importance: Improving care during the postpartum period is a clinical and policy priority. During the comprehensive postpartum visit, guidelines recommend delivery of a large number of assessment, screening, and counseling services. However, little is known about services provided during these visits.
View Article and Find Full Text PDFStability in effects of different smoking-related polygenic risk scores over age and smoking phenotypes.
Drug Alcohol Depend
September 2020
Sanford Research, Behavioral Sciences, United States; University of South Dakota School of Medicine, Pediatrics, United States.
Purpose: Polygenic risk scores (PRSs) for smoking behavior largely fail to consider the demonstrated developmental change in genetic influence over age and stage of smoking behaviors. Additionally, few studies have examined how stage-specific smoking PRSs (e.g.
View Article and Find Full Text PDFA tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities.
Am J Addict
November 2010
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Tobacco dependence is the leading cause of death in persons with psychiatric and substance use disorders. This has lead to interest in the development of pharmacological and behavioral treatments for tobacco dependence in this subset of smokers. However, there has been little attention paid to the development of tobacco-free environments in psychiatric institutions despite the creation of smoke-free psychiatric hospitals mandated by the Joint Commission for Accreditation of Health Organizations (JCAHO) in 1992.
View Article and Find Full Text PDFGetting it right: designing adolescent-centred smoking cessation services.
Addiction
July 2007
Cardiff Institute of Society, Health and Ethics, School of Social Sciences, Cardiff University, Cardiff, Wales, UK.
Aims: To demonstrate the importance of identifying adolescent preferences for smoking cessation in order to inform the design of effective adolescent cessation services.
Design: Structured qualitative interviews drawing on means-end theory.
Setting: Three youth-clubs and two secondary schools in south-east Wales.
Out of the ashes: the life, death, and rebirth of the "safer" cigarette in the United States.
Am J Public Health
February 2004
Center for the History and Ethics of Public Health, Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
From 1964 through the early 1980s, both federal and voluntary agencies endorsed the concept of "safer" cigarettes. Beginning in the mid-1980s, several factors, including revelations of tobacco industry malfeasance, the development of nicotine replacement therapy, and the reconceptualization of smoking as a chronic disease, led to "safer" cigarettes being discredited. In the past few years, some public health professionals have begun to reconsider the viability of developing such products.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!